Gregory D Davis Sangamo Therapeutics, Inc (SGMO) insider trading activity
Gregory D Davis is Head of Research & Technology of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 208,653 shares of SGMO, which is worth approximately $95,980. The most recent transaction as insider was on May 24, 2025, when has been sold 723 shares (Common Stock) at a price of $0.47 per share, resulting in proceeds of $339. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
209K
25.42%
3M change
n/a
12M change
Total Value Held
$95,980
Gregory D Davis Transaction History
GDD
Gregory D Davis
Head of Research & Technology
Richmond, CA